UnderwriteMe has enhanced its question set on the Protection Platform to accurately capture the use of weight-loss treatment, allowing insurer partners to apply decisions in line with their underwriting risk appetite.
Additional questions will focus on the type of weight-loss treatment, how long it has been used for, and what the impact has been.
Seven insurers are currently offering buy-now decisions subject to the answers provided.
“After speaking to our insurer partners, we felt it was the right time to enhance the question set so they can continue to evolve their underwriting philosophies,” said Nilesh Patel, chief revenue and customer officer at UnderwriteMe.
Vitality completes integration of SIC products with UnderwriteMe
Amid increasing consumer usage, the Protection Platform has received 739 applications disclosing weight-loss treatment, including Ozempic and Mounjaro.
In response to this platform update, Chris Reed, marketing director at Protect Line, added: “The world our customers live in is moving much faster – from the rapid rise of weight-loss treatments to the way Gen Z think about health and lifestyle – and our questions haven’t always kept pace.
“By asking smarter, more nuanced questions about clinically supervised weight loss, UnderwriteMe is helping distributors secure fair, timely outcomes for customers who are simply trying to take control of their health.”
